Connective Tissue and Related Disorders and Preterm Birth: Clues to Genes Contributing to Prematurity

Placenta

Volumn 30, Issue 3, 2009, Pages 207-215

  Anum, E A ^a   Hill, L D ^a   Pandya, A ^b   Strauss III, J F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cervical incompetence; Connective tissue; Genes; PPROM; Preterm birth

Indexed keywords

FIBRILLIN 1; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA1;

ADAMTS2 GENE; ARTICLE; COL1A1 GENE; COL1A2 GENE; COL3A1 GENE; COL5A1 GENE; COL5A2 GENE; CONNECTIVE TISSUE DISEASE; CRTAP GENE; CUTIS LAXA; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EHLERS DANLOS SYNDROME; EPIDERMOLYSIS BULLOSA; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; LEPRE1 GENE; MARFAN SYNDROME; OSTEOGENESIS IMPERFECTA; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN DISEASE; TNXB GENE; UTERINE CERVIX INCOMPETENCE; ZMPSTE24 GENE;

COLLAGEN DISEASES; CUTIS LAXA; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; MARFAN SYNDROME; PREGNANCY; PREMATURE BIRTH; UTERINE CERVICAL INCOMPETENCE;

EID: 59849095523     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.12.007     Document Type: Article

References (137)

1. Parry S., and Strauss III J.F. Premature rupture of the fetal membranes. N Engl J Med 338 (1998) 663-670
2. Oxlund H., Helmig R., Halaburt J.T., and Uldbjerg N. Biomechanical analysis of human chorioamniotic membranes. Eur J Obstet Gynecol Reprod Biol 34 (1990) 247-255
3. Helmig R., Oxlund H., Petersen L.K., and Uldbjerg N. Different biomechanical properties of human fetal membranes obtained before and after delivery. Eur J Obstet Gynecol Reprod Biol 48 (1993) 183-189
4. Wang H., Parry S., Macones G., Sammel M.D., Kuivaniemi H., Tromp G., et al. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A 103 (2006) 13463-13467
5. Moore R.M., Mansour J.M., Redline R.W., Mercer B.M., and Moore J.J. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 27 (2006) 1037-1051
6. Malak T.M., Ockleford C.D., Bell S.C., Dalgleish R., Bright N., and Macvicar J. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta 14 (1993) 385-406
7. Hieber A.D., Corcino D., Motosue J., Sandberg L.B., Roos P.J., Yu S.Y., et al. Detection of elastin in the human fetal membranes: proposed molecular basis for elasticity. Placenta 18 (1997) 301-312
8. Malak T.M., and Bell S.C. Distribution of fibrillin-containing microfibrils and elastin in human fetal membranes: a novel molecular basis for membrane elasticity. Am J Obstet Gynecol 171 (1994) 195-205
9. Heaps B.R., House M., Socrate S., Leppert P., and Strauss III J.F. Matrix biology and preterm birth. In: Petraglia F., Strauss III J.F., Gabbe S.G., and Weiss G. (Eds). Preterm birth (2007), Informa Press, Oxford, England 70-93
10. Barabas A.P. Ehlers-Danlos syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence. Br Med J 2 (1966) 682-684
11. Lind J., and Wallenburg H.C. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 81 (2002) 293-300
12. Witt D.R., Hayden M.R., Holbrook K.A., Dale B.A., Baldwin V.J., and Taylor G.P. Restrictive dermopathy: a newly recognized autosomal recessive skin dysplasia. Am J Med Genet 24 (1986) 631-648
13. Mau U., Kendziorra H., Kaiser P., and Enders H. Restrictive dermopathy: report and review. Am J Med Genet 71 (1997) 179-185
14. Wesche W.A., Cutlan R.T., Khare V., Chesney T., and Shanklin D. Restrictive dermopathy: report of a case and review of the literature. J Cutan Pathol 28 (2001) 211-218
15. Dolan C.R., Smith L.T., and Sybert V.P. Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein. Am J Med Genet 47 (1993) 395-400
16. Shaw D.W., Fine J.D., Piacquadio D.J., Greenberg M.J., Wang-Rodriguez J., and Eichenfield L.F. Gastric outlet obstruction and epidermolysis bullosa. J Am Acad Dermatol 36 (1997) 304-310
17. De Jenlis Sicot B., Deruelle P., Kacet N., Vaillant C., and Subtil D. Prenatal findings in epidermolysis bullosa with pyloric atresia in a family not known to be at risk. Ultrasound Obstet Gynecol 25 (2005) 607-609
18. Lind J., and Wallenburg H.C. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 98 (2001) 28-35
19. Rossiter J.P., Repke J.T., Morales A.J., Murphy E.A., and Pyeritz R.E. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 173 (1995) 1599-1606
20. Badauy C.M., Gomes S.S., Sant'Ana Filho M., and Chies J.A. Ehlers-Danlos syndrome (EDS) type IV: review of the literature. Clin Oral Investig 11 (2007) 183-187
21. Parapia L.A., and Jackson C. Ehlers-Danlos syndrome - a historical review. Br J Haematol 141 (2008) 32-35
22. Karrer S., Landthaler M., and Schmalz G. Ehlers-Danlos type VIII. Review of the literature. Clin Oral Investig 4 (2000) 66-69
23. De Coster P.J., Cornelissen M., De Paepe A., Martens L.C., and Vral A. Abnormal dentin structure in two novel gene mutations [COL1A1, Arg134Cys] and [ADAMTS2, Trp795-to-ter] causing rare type I collagen disorders. Arch Oral Biol 52 (2007) 101-109
24. Pyeritz R.E. Ehlers-Danlos syndrome. N Engl J Med 342 (2000) 730-732
25. Germain D.P. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2 (2007) 32
26. Ainsworth S.R., and Aulicino P.L. A survey of patients with Ehlers-Danlos syndrome. Clin Orthop Relat Res 286 (1993) 250-256
27. Sorokin Y., Johnson M.P., Rogowski N., Richardson D.A., and Evans M.I. Obstetric and gynecologic dysfunction in the Ehlers-Danlos syndrome. J Reprod Med 39 (1994) 281-284
28. Yen J.L., Lin S.P., Chen M.R., and Niu D.M. Clinical features of Ehlers-Danlos syndrome. J Formos Med Assoc 105 (2006) 475-480
29. Volkov N., Nisenblat V., Ohel G., and Gonen R. Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv 62 (2007) 51-57
30. Snyder R.R., Gilstrap L.C., and Hauth J.C. Ehlers-Danlos syndrome and pregnancy. Obstet Gynecol 61 (1983) 649-650
31. Ploeckinger B., Ulm M.R., and Chalubinski K. Ehlers-Danlos syndrome type II in pregnancy. Am J Perinatol 14 (1997) 99-101
32. Munz W., Schlembach D., Beinder E., and Fischer T. Ehlers-Danlos syndrome type I in pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 99 (2001) 126-128
33. Roop K.A., and Brost B.C. Abnormal presentation in labor and fetal growth of affected infants with type III Ehlers-Danlos syndrome. Am J Obstet Gynecol 181 (1999) 752-753
34. Morales-Rosello J., Hernandez-Yago J., and Pope M. Type III Ehlers-Danlos syndrome and pregnancy. Arch Gynecol Obstet 261 (1997) 39-43
35. Jaleel S., and Olah K. Ehlers-Danlos syndrome in pregnancy. J Obstet Gynaecol 27 (2007) 420-421
36. Golfier F., Peyrol S., Attia-Sobol J., Marret H., Raudrant D., and Plauchu H. Hypermobility type of Ehlers-Danlos syndrome: influence of pregnancies. Clin Genet 60 (2001) 240-241
37. Bruno P.A., Napolitano V., Votino F., Di Mauro P., and Nappi C. Pregnancy and delivery in Ehlers-Danlos syndrome type V. Clin Exp Obstet Gynecol 24 (1997) 152-153
38. Kiilholma P., Gronroos M., Nanto V., and Paul R. Pregnancy and delivery in Ehlers-Danlos syndrome. Role of copper and zinc. Acta Obstet Gynecol Scand 63 (1984) 437-439
39. Smith S.A., Powell L.C., and Essin E.M. Ehlers-Danlos syndrome and pregnancy. Report of a case. Obstet Gynecol 32 (1968) 331-335
40. Kulkarni S., and LaGrenade L. Ehlers-Danlos syndrome in pregnancy. West Indian Med J 41 (1992) 86-87
41. De Vos M., Nuytinck L., Verellen C., and De Paepe A. Preterm premature rupture of membranes in a patient with the hypermobility type of the Ehlers-Danlos syndrome. A case report. Fetal Diagn Ther 14 (1999) 244-247
42. Fujimoto A., Wilcox W.R., and Cohn D.H. Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC. Am J Med Genet 68 (1997) 25-28
43. Lurie S., Manor M., and Hagay Z.J. The threat of type IV Ehlers-Danlos syndrome on maternal well-being during pregnancy: early delivery may make the difference. J Obstet Gynaecol 18 (1998) 245-248
44. Young I.D., Lindenbaum R.H., Thompson E.M., and Pembrey M.E. Amniotic bands in connective tissue disorders. Arch Dis Child 60 (1985) 1061-1063
45. Taylor D.J., Wilcox I., and Russell J.K. Ehlers-Danlos syndrome during pregnancy: a case report and review of the literature. Obstet Gynecol Surv 36 (1981) 277-281
46. Atalla A., and Page I. Ehlers-Danlos syndrome type III in pregnancy. Obstet Gynecol 71 (1988) 508-509
47. Wood J. Care study Pregnancy and Ehlers-Danlos syndrome type IV. Midwives Chron 106 (1993) 446-448
48. Hermanns-Le T., Pierard G., and Quatresooz P. Ehlers-Danlos-like dermal abnormalities in women with recurrent preterm premature rupture of fetal membranes. Am J Dermatopathol 27 (2005) 407-410
49. Malfait F., and De Paepe A. Molecular genetics in classic Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 139C (2005) 17-23
50. Pepin M., Schwarze U., Superti-Furga A., and Byers P.H. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342 (2000) 673-680
51. Brusin J.H. Osteogenesis imperfecta. Radiol Technol 79 (2008) 535-548 quiz 549-51
52. Glorieux F.H. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol 22 (2008) 85-100
53. Baldridge D., Schwarze U., Morello R., Lennington J., Bertin T.K., Pace J.M., et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat (2008)
54. Morello R., Bertin T.K., Chen Y., Hicks J., Tonachini L., Monticone M., et al. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127 (2006) 291-304
55. Martin E., and Shapiro J.R. Osteogenesis imperfecta: epidemiology and pathophysiology. Curr Osteoporos Rep 5 (2007) 91-97
56. Barnes A.M., Chang W., Morello R., Cabral W.A., Weis M., Eyre D.R., et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355 (2006) 2757-2764
57. Sillence D.O., Senn A., and Danks D.M. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16 (1979) 101-116
58. Rauch F., and Glorieux F.H. Osteogenesis imperfecta. Lancet 363 (2004) 1377-1385
59. Cheung M.S., and Glorieux F.H. Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 9 (2008) 153-160
60. Taksande A., Vilhekar K., and Khangare S. Osteogenesis imperfecta type II with congenital heart disease. Iran J Pediatr 18 2 (2008) 175-178
61. Marini J.C., Forlino A., Cabral W.A., Barnes A.M., San Antonio J.D., Milgrom S., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28 (2007) 209-221
62. Key T.C., and Horger III E.O. Osteogenesis imperfecta as a complication of pregnancy. Obstet Gynecol 51 (1978) 67-71
63. Byrne B.M., and Morrison J.J. Prenatal diagnosis of lethal fetal malformation in Irish obstetric practice. Ir Med J 92 (1999) 271-273
64. Teng S.W., Guo W.Y., Sheu M.H., and Wang P.H. Initial experience using magnetic resonance imaging in prenatal diagnosis of osteogenesis imperfecta type II: a case report. Clin Imaging 27 (2003) 55-58
65. Cho E., Dayan S.S., and Marx G.F. Anaesthesia in a parturient with osteogenesis imperfecta. Br J Anaesth 68 (1992) 422-423
66. Brady A.F., and Patton M.A. Osteogenesis imperfecta with arthrogryposis multiplex congenita (Bruck syndrome) - evidence for possible autosomal recessive inheritance. Clin Dysmorphol 6 (1997) 329-336
67. Chen C.P., Su Y.N., Lin S.P., Lin M.L., and Wang W. Favourable outcome in a pregnancy with concomitant maternal and fetal osteogenesis imperfecta associated with a novel COL1A2 mutation. Prenat Diagn 26 (2006) 188-190
68. Parasuraman R., Taylor M.J., Liversedge H., and Gilg J. Pregnancy management in type III maternal osteogenesis imperfecta. J Obstet Gynaecol 27 (2007) 619-621
69. Anderer G., Hellmeyer L., and Hadji P. Clinical management of a pregnant patient with type I osteogenesis imperfecta using quantitative ultrasonometry - a case report. Ultraschall Med 29 (2008) 201-204
70. Chan B., and Zacharin M. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 91 (2006) 2017-2020
71. Datta V., Sinha A., Saili A., and Nangia S. Bruck syndrome. Indian J Pediatr 72 (2005) 441-442
72. Cole W.G., Patterson E., Bonadio J., Campbell P.E., and Fortune D.W. The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen. J Med Genet 29 (1992) 112-118
73. Rodriguez J.I., Perera A., Regadera J., Collado F., and Contreras F. Lethal osteogenesis imperfecta. Anatomopathologic (optical and structural) study of 8 autopsy cases. An Esp Pediatr 17 (1982) 18-33
74. Fine J.D. Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin beta4. Ann N Y Acad Sci 1112 (2007) 396-406
75. Fine J.D., Eady R.A., Bauer E.A., Bauer J.W., Bruckner-Tuderman L., Heagerty A., et al. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 58 (2008) 931-950
76. Uitto J. Epidermolysis bullosa: prospects for cell-based therapies. J Invest Dermatol 128 (2008) 2140-2142
77. Buscher U., Wessel J., Anton-Lamprecht I., and Dudenhausen J.W. Pregnancy and delivery in a patient with mutilating dystrophic epidermolysis bullosa (Hallopeau-Siemens type). Obstet Gynecol 89 (1997) 817-820
78. Price T., and Katz V.L. Obstetrical concerns of epidermolysis bullosa. Obstet Gynecol Surv 43 (1988) 445-449
79. Baloch M.S., Fitzwilliams B., Mellerio J., Lakasing L., Bewley S., and O'Sullivan G. Anaesthetic management of two different modes of delivery in patients with dystrophic epidermolysis bullosa. Int J Obstet Anesth 17 (2008) 153-158
80. Broster T., Placek R., and Eggers Jr. G.W. Epidermolysis bullosa: anesthetic management for cesarean section. Anesth Analg 66 (1987) 341-343
81. Fine J.D., Eady R.A., Levy M.L., Hejtmancik J.F., Courtney K.B., Carpenter R.J., et al. Prenatal diagnosis of dominant and recessive dystrophic epidermolysis bullosa: application and limitations in the use of KF-1 and LH 7:2 monoclonal antibodies and immunofluorescence mapping technique. J Invest Dermatol 91 (1988) 465-471
82. Berryhill R.E., Benumof J.L., Saidman L.J., Smith P.C., and Plumer M.H. Anesthetic management of emergency cesarean section in a patient with epidermolysis bullosa dystrophica polydysplastica. Anesth Analg 57 (1978) 281-283
83. Bianca S., Reale A., and Ettore G. Pregnancy and cesarean delivery in a patient with dystrophic epidermolysis bullosa. Eur J Obstet Gynecol Reprod Biol 110 (2003) 235-236
84. Goldstein A.M., Davenport T., and Sheridan R.L. Junctional epidermolysis bullosa: diagnosis and management of a patient with the Herlitz variant. J Pediatr Surg 33 (1998) 756-758
85. Takizawa Y., Pulkkinen L., Shimizu H., Lin L., Hagiwara S., Nishikawa T., et al. Maternal uniparental meroisodisomy in the LAMB3 region of chromosome 1 results in lethal junctional epidermolysis bullosa. J Invest Dermatol 110 (1998) 828-831
86. Azarian M., Dreux S., Vuillard E., Meneguzzi G., Haber S., Guimiot F., et al. Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review. Prenat Diagn 26 (2006) 57-59
87. Nazzaro V., Nicolini U., De Luca L., Berti E., and Caputo R. Prenatal diagnosis of junctional epidermolysis bullosa associated with pyloric atresia. J Med Genet 27 (1990) 244-248
88. Marras A., Dessi C., and Macciotta A. Epidermolysis bullosa and amniotic bands. Am J Med Genet 19 (1984) 815-817
89. Aubard Y., Genet C., Bedane C., and Gilbert B. Prenatal diagnosis of hereditary bullous epidermolysis. A case report. J Gynecol Obstet Biol Reprod (Paris) 25 (1996) 588-593
90. Puvabanditsin S., Garrow E., Kim D.U., Tirakitsoontorn P., and Luan J. Junctional epidermolysis bullosa associated with congenital localized absence of skin, and pyloric atresia in two newborn siblings. J Am Acad Dermatol 44 (2001) 330-335
91. Peltier F.A., Tschen E.H., Raimer S.S., and Kuo T.T. Epidermolysis bullosa letalis associated with congenital pyloric atresia. Arch Dermatol 117 (1981) 728-731
92. Fox A.T., Alderdice F., and Atherton D.J. Are children with recessive dystrophic epidermolysis bullosa of low birthweight?. Pediatr Dermatol 20 (2003) 303-306
93. Nijsten T.E., De Moor A., Colpaert C.G., Robert K., Mahieu L.M., and Lambert J. Restrictive dermopathy: a case report and a critical review of all hypotheses of its origin. Pediatr Dermatol 19 (2002) 67-72
94. van der Stege J.G., van Straaten H.L., van der Wal A.C., and van Eyck J. Restrictive dermopathy and associated prenatal ultrasound findings: case report. Ultrasound Obstet Gynecol 10 (1997) 140-141
95. Sander C.S., Salman N., van Geel M., Broers J.L., Al-Rahmani A., Chedid F., et al. A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle East. Br J Dermatol 159 (2008) 961-967
96. Thill M., Nguyen T.D., Wehnert M., Fischer D., Hausser I., Braun S., et al. Restrictive dermopathy: a rare laminopathy. Arch Gynecol Obstet 278 (2008) 201-208
97. Smitt J.H., van Asperen C.J., Niessen C.M., Beemer F.A., van Essen A.J., Hulsmans R.F., et al. Restrictive dermopathy. Report of 12 cases. Dutch Task Force on Genodermatology. Arch Dermatol 134 (1998) 577-579
98. Kim Y.N., Jeong D.H., Jeong S.J., Sung M.S., Kang M.S., and Kim K.T. Complete chorioamniotic membrane separation with fetal restrictive dermopathy in two consecutive pregnancies. Prenat Diagn 27 (2007) 352-355
99. Navarro C.L., Cadinanos J., De Sandre-Giovannoli A., Bernard R., Courrier S., Boccaccio I., et al. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of lamin A precursors. Hum Mol Genet 14 (2005) 1503-1513
100. Moulson C.L., Go G., Gardner J.M., van der Wal A.C., Smitt J.H., van Hagen J.M., et al. Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol 125 (2005) 913-919
101. Bergo M.O., Gavino B., Ross J., Schmidt W.K., Hong C., Kendall L.V., et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A 99 (2002) 13049-13054
102. Pendas A.M., Zhou Z., Cadinanos J., Freije J.M., Wang J., Hultenby K., et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31 (2002) 94-99
103. Pyeritz R.E. The Marfan syndrome. Annu Rev Med 51 (2000) 481-510
104. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 (1991) 337-339
105. Pearson G.D., Devereux R., Loeys B., Maslen C., Milewicz D., Pyeritz R., et al., National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 118 (2008) 785-791
106. Lipscomb K.J., Smith J.C., Clarke B., Donnai P., and Harris R. Outcome of pregnancy in women with Marfan's syndrome. Br J Obstet Gynaecol 104 (1997) 201-206
107. Pyeritz R.E. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 71 (1981) 784-790
108. Liang S.T. Marfan syndrome, recurrent preterm labour and grandmultiparity. Aust N Z J Obstet Gynaecol 25 (1985) 288-289
109. Meijboom L.J., Drenthen W., Pieper P.G., Groenink M., van der Post J.A., Timmermans J., et al., ZAHARA Investigators. Obstetric complications in Marfan syndrome. Int J Cardiol 110 (2006) 53-59
110. Rahman J., Rahman F.Z., Rahman W., al-Suleiman S.A., and Rahman M.S. Obstetric and gynecologic complications in women with Marfan syndrome. J Reprod Med 48 (2003) 723-728
111. Beighton P. The dominant and recessive forms of cutis laxa. J Med Genet 9 (1972) 216-221
112. Byers P.H., Siegel R.C., Holbrook K.A., Narayanan A.S., Bornstein P., and Hall J.G. X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med 303 (1980) 61-65
113. Hamalainen E.R., Jones T.A., Sheer D., Taskinen K., Pihlajaniemi T., and Kivirikko K.I. Molecular cloning of human lysyl oxidase and assignment of the gene to chromosome 5q23.3-31.2. Genomics 11 (1991) 508-516
114. Loeys B., Van Maldergem L., Mortier G., Coucke P., Gerniers S., Naeyaert J.M., et al. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11 (2002) 2113-2118
115. Szabo Z., Crepeau M.W., Mitchell A.L., Stephan M.J., Puntel R.A., Yin Loke K., et al. Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 43 (2006) 255-258
116. Markova D., Zou Y., Ringpfeil F., Sasaki T., Kostka G., Timpl R., et al. Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 72 (2003) 998-1004
117. Graul-Neumann L.M., Hausser I., Essayie M., Rauch A., and Kraus C. Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene. Am J Med Genet A 146A (2008) 977-983
118. Rodriguez-Revenga L., Iranzo P., Badenas C., Puig S., Carrio A., and Mila M. A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. Arch Dermatol 140 (2004) 1135-1139
119. Hu Q., Loeys B.L., Coucke P.J., De Paepe A., Mecham R.P., Choi J., et al. Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. Hum Mol Genet 15 (2006) 3379-3386
120. Patton M.A., Tolmie J., Ruthnum P., Bamforth S., Baraitser M., and Pembrey M. Congenital cutis laxa with retardation of growth and development. J Med Genet 24 (1987) 556-561
121. Nanda A., Lionel J., Al-Tawari A.A., and Anim J.T. What syndrome is this? Autosomal recessive type II cutis laxa. Pediatr Dermatol 21 (2004) 167-170
122. Marchase P., Holbrook K., and Pinnell S.R. A familial cutis laxa syndrome with ultrastructural abnormalities of collagen and elastin. J Invest Dermatol 75 (1980) 399-403
123. Dogra N., Kalsotra P., and Dogra D. Congenital generalized cutis laxa in two sisters. Indian J Dermatol Venereol Leprol 70 (2004) 108-109
124. Andiran N., Sarikayalar F., Saraclar M., and Caglar M. Autosomal recessive form of congenital cutis laxa: more than the clinical appearance. Pediatr Dermatol 19 (2002) 412-414
125. Khakoo A., Thomas R., Trompeter R., Duffy P., Price R., and Pope F.M. Congenital cutis laxa and lysyl oxidase deficiency. Clin Genet 51 (1997) 109-114
126. Koklu E., Gunes T., Ozturk M.A., Akcakus M., Buyukkayhan D., and Kurtoglu S. Cutis laxa associated with central hypothyroidism owing to isolated thyrotropin deficiency in a newborn. Pediatr Dermatol 24 (2007) 525-528
127. Gupta N., and Phadke S.R. Cutis laxa type II and wrinkly skin syndrome: distinct phenotypes. Pediatr Dermatol 23 (2006) 225-230
128. Leduc L., and Wasserstrum N. Successful treatment with the Smith-Hodge pessary of cervical incompetence due to defective connective tissue in Ehlers-Danlos syndrome. Am J Perinatol 9 (1992) 25-27
129. Tzialidou I., Oehler K., Scharf A., Staboulidou I., Westhoff-Bleck M., Hillemanns P., et al. Marfan syndrome in pregnancy: presentation of four cases and discussion. Z Geburtshilfe Neonatol 211 (2007) 36-41
130. Paternoster D.M., Santarossa C., Vettore N., Dalla Pria S., and Grella P. Obstetric complications in Marfan's syndrome pregnancy. Minerva Ginecol 50 (1998) 441-443
131. Warren J.E., Silver R.M., Dalton J., Nelson L.T., Branch D.W., and Porter T.F. Collagen 1Alpha1 and transforming growth factor-beta polymorphisms in women with cervical insufficiency. Obstet Gynecol 110 (2007) 619-624
132. Fujimoto T., Parry S., Urbanek M., Sammel M., Macones G., Kuivaniemi H., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 277 (2002) 6296-6302
133. Ferrand P.E., Parry S., Sammel M., Macones G.A., Kuivaniemi H., Romero R., et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 8 (2002) 494-501
134. Wang H., Parry S., Macones G., Sammel M.D., Ferrand P.E., Kuivaniemi H., et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 13 (2004) 2659-2669
135. Wang H., Sammel M.D., Tromp G., Gotsch F., Halder I., Shriver M.D., et al. A 12-bp deletion in the 5′-flanking region of the SERPINH1 gene affects promoter activity and protects against preterm premature rupture of membranes in African Americans. Hum Mutat 29 (2008) 332
136. Wang H., Ogawa M., Wood J.R., Bartolomei M.S., Sammel M.D., Kusanovic J.P., et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet 17 (2008) 1087-1096
137. Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A., et al. Natural variation in four human collagen genes across an ethnically diverse population. Genomics 91 (2008) 307-314